Skip to content

Clinical trials

Phase 2 Mesothelioma, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 2 Country / region: United States Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20022
20032
20043
20052
20062
20072
20083
20092
20104
20134
20152
20162
20174
20181
20191
20212
20221
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated12
Recruiting4
Unknown status3
Active, not recruiting3
Withdrawn1
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
Alliance for Clinical Trials in Oncology5
Memorial Sloan Kettering Cancer Center4
M.D. Anderson Cancer Center3
Columbia University2
Dana-Farber Cancer Institute2
Morphotek2
SWOG Cancer Research Network2
University of Chicago2
Verastem, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant58
Solitary Fibrous Tumor, Pleural17
Mesothelioma11
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms4
Small Cell Lung Carcinoma4
Carcinoma, Neuroendocrine2
Colorectal Neoplasms2
Nasopharyngeal Carcinoma2
Pancreatic Neoplasms2

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.